NovoCyte Starter Kit V2, Part Number 8100002

Agilent Technologies Manufacturing GmbH & Co. KG

Revision date : 2020-04-06

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

7681-49-4

Name of the chemical

Sodium fluoride

Concentration

N/A

EC/CAS

231-667-8

Name of the chemical

Sodium fluoride

Concentration

N/A

General Information

Revision date

2020-04-06

Product name

NovoCyte Starter Kit V2, Part Number 8100002

Emergency telephone

+(44)-870-8200418

Icons in SDS

Company Information

company name

Agilent Technologies Manufacturing GmbH & Co. KG

e-mail address of the competent person responsible for the Safety Data Sheet

pdl-msds_author@agilent.com

GHS Information

Signal word

Warning

Hazard Codes

Hazard statements (CLP)

H373

Hazard statements

Code

Statements

H373

May cause damage to organs through prolonged or repeated exposure

Section 2

SECTION 2: Hazards identification

Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]

Product definition

NovoFlow solution Mixture NovoRinse solution Mixture NovoCyte QC Particles Mixture (generation 2)

CLP CLASSIFICATION

NovoFlow solution H373 SPECIFIC TARGET ORGAN TOXICITY - REPEATED EXPOSURE Ingredients of unknown : NovoFlow solution Percentage of the mixture consisting of ingredient(s) of toxicity unknown acute dermal toxicity: 10 - 30% See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.

Hazard pictograms

NovoFlow solution

Signal word

NovoFlow solution Warning NovoRinse solution No signal word. NovoCyte QC Particles No signal word. (generation 2)

Hazard statements

NovoFlow solution H373 - May cause damage to organs through prolonged or repeated exposure. NovoRinse solution No known significant effects or critical hazards. NovoCyte QC Particles No known significant effects or critical hazards. (generation 2)

Prevention

NovoFlow solution P260 - Do not breathe vapour. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)

Response

NovoFlow solution P314 - Get medical advice/attention if you feel unwell. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)

Storage

NovoFlow solution Not applicable. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)

Disposal

NovoFlow solution P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations. NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)

Hazardous Ingredients

NovoFlow solution - Acetic acid, (ethylenedinitrilo)tetra-, disodium salt, dihydrate

Supplemental label elements

NovoFlow solution Not applicable. elements NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2) Annex XVII - Restrictions : NovoFlow solution Not applicable. on the manufacture, NovoRinse solution Not applicable. placing on the market NovoCyte QC Particles Not applicable. and use of certain (generation 2) dangerous substances, mixtures and articles

Special packaging requirements

Tactile warning of NovoFlow solution Not applicable. danger NovoRinse solution Not applicable. NovoCyte QC Particles Not applicable. (generation 2)

2.3 Other hazards

Product meets the : NovoFlow solution This mixture does not contain any substances that are criteria for PBT or vPvB assessed to be a PBT or a vPvB. according to NovoRinse solution This mixture does not contain any substances that are Regulation (EC) No. assessed to be a PBT or a vPvB. 1907/2006, Annex XIII NovoCyte QC Particles This mixture does not contain any substances that are (generation 2) assessed to be a PBT or a vPvB. Other hazards which do : NovoFlow solution None known. not result in NovoRinse solution None known.

Classifications

NovoCyte QC Particles None known. (generation 2)

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.